Literature DB >> 25727379

Relaxation-compensated CEST-MRI of the human brain at 7T: Unbiased insight into NOE and amide signal changes in human glioblastoma.

Moritz Zaiss1, Johannes Windschuh2, Daniel Paech3, Jan-Eric Meissner4, Sina Burth3, Benjamin Schmitt5, Philip Kickingereder6, Benedikt Wiestler7, Wolfgang Wick7, Martin Bendszus6, Heinz-Peter Schlemmer8, Mark E Ladd2, Peter Bachert2, Alexander Radbruch3.   

Abstract

Endogenous chemical exchange saturation transfer (CEST) effects of protons resonating near to water protons are always diluted by competing effects such as direct water saturation and semi-solid magnetization transfer (MT). This leads to unwanted T2 and MT signal contributions that contaminate the observed CEST signal. Furthermore, all CEST effects appear to be scaled by the T1 relaxation time of the mediating water pool. As MT, T1 and T2 are also altered in tumor regions, a recently published correction algorithm yielding the apparent exchange-dependent relaxation AREX, is used to evaluate in vivo CEST effects. This study focuses on CEST effects of amides (3.5ppm) and Nuclear-Overhauser-mediated saturation transfer (NOE, -3.5ppm) that can be properly isolated at 7T. These were obtained in 10 glioblastoma patients, and this is the first comprehensive study where AREX is applied in human brain as well as in human glioblastoma. The correction of CEST effects alters the contrast significantly: after correction, the CEST effect of amides does not show significant contrast between contrast enhancing tumor regions and normal tissue, whereas NOE drops significantly in the tumor area. In addition, new features in the AREX contrasts are visible. This suggests that previous CEST approaches might not have shown pure CEST effects, but rather water relaxation shine-through effects. Our insights help to improve understanding of the CEST effect changes in tumors and correlations on a cellular and molecular level.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  7T high resolution; AREX; CEST; Comprehensive CEST study; Glioblastoma; NOE; Relaxation compensation; Relaxation-compensated CEST; Spillover correction

Mesh:

Substances:

Year:  2015        PMID: 25727379     DOI: 10.1016/j.neuroimage.2015.02.040

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  58 in total

1.  Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.

Authors:  Daniel Paech; Constantin Dreher; Sebastian Regnery; Jan-Eric Meissner; Steffen Goerke; Johannes Windschuh; Johanna Oberhollenzer; Miriam Schultheiss; Katerina Deike-Hofmann; Sebastian Bickelhaupt; Alexander Radbruch; Moritz Zaiss; Andreas Unterberg; Wolfgang Wick; Martin Bendszus; Peter Bachert; Mark E Ladd; Heinz-Peter Schlemmer
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

2.  Simultaneous pH-sensitive and oxygen-sensitive MRI of human gliomas at 3 T using multi-echo amine proton chemical exchange saturation transfer spin-and-gradient echo echo-planar imaging (CEST-SAGE-EPI).

Authors:  Robert J Harris; Jingwen Yao; Ararat Chakhoyan; Catalina Raymond; Kevin Leu; Linda M Liau; Phioanh L Nghiemphu; Albert Lai; Noriko Salamon; Whitney B Pope; Timothy F Cloughesy; Benjamin M Ellingson
Journal:  Magn Reson Med       Date:  2018-04-06       Impact factor: 4.668

3.  CEST MR-Fingerprinting: Practical considerations and insights for acquisition schedule design and improved reconstruction.

Authors:  Or Perlman; Kai Herz; Moritz Zaiss; Ouri Cohen; Matthew S Rosen; Christian T Farrar
Journal:  Magn Reson Med       Date:  2019-08-09       Impact factor: 4.668

4.  Quantitative assessment of amide proton transfer (APT) and nuclear overhauser enhancement (NOE) imaging with extrapolated semisolid magnetization transfer reference (EMR) signals: II. Comparison of three EMR models and application to human brain glioma at 3 Tesla.

Authors:  Hye-Young Heo; Yi Zhang; Shanshan Jiang; Dong-Hoon Lee; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2015-05-28       Impact factor: 4.668

5.  Tumor pH and Protein Concentration Contribute to the Signal of Amide Proton Transfer Magnetic Resonance Imaging.

Authors:  Kevin J Ray; Manon A Simard; James R Larkin; James Coates; Paul Kinchesh; Sean C Smart; Geoff S Higgins; Michael A Chappell; Nicola R Sibson
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

6.  CEST imaging of fast exchanging amine pools with corrections for competing effects at 9.4 T.

Authors:  Xiao-Yong Zhang; Feng Wang; Hua Li; Junzhong Xu; Daniel F Gochberg; John C Gore; Zhongliang Zu
Journal:  NMR Biomed       Date:  2017-03-08       Impact factor: 4.044

7.  Accuracy in the quantification of chemical exchange saturation transfer (CEST) and relayed nuclear Overhauser enhancement (rNOE) saturation transfer effects.

Authors:  Xiao-Yong Zhang; Feng Wang; Hua Li; Junzhong Xu; Daniel F Gochberg; John C Gore; Zhongliang Zu
Journal:  NMR Biomed       Date:  2017-03-08       Impact factor: 4.044

8.  R1 correction in amide proton transfer imaging: indication of the influence of transcytolemmal water exchange on CEST measurements.

Authors:  Hua Li; Ke Li; Xiao-Yong Zhang; Xiaoyu Jiang; Zhongliang Zu; Moritz Zaiss; Daniel F Gochberg; John C Gore; Junzhong Xu
Journal:  NMR Biomed       Date:  2015-10-14       Impact factor: 4.044

Review 9.  Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.

Authors:  Peter C M van Zijl; Wilfred W Lam; Jiadi Xu; Linda Knutsson; Greg J Stanisz
Journal:  Neuroimage       Date:  2017-04-21       Impact factor: 6.556

10.  Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.

Authors:  Rachel W Chan; Hanbo Chen; Sten Myrehaug; Eshetu G Atenafu; Greg J Stanisz; James Stewart; Pejman Jabehdar Maralani; Aimee K M Chan; Shadi Daghighi; Mark Ruschin; Sunit Das; James Perry; Gregory J Czarnota; Arjun Sahgal; Angus Z Lau
Journal:  J Neurooncol       Date:  2020-11-16       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.